Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation

NCT00168077 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00168077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2006
Enrollment
40
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acquired coagulation factor deficiency